News - HealthQuill

Marathons may affect the brain causing the organ to eat itself to make up for fuel lost during the run, and the effect is reversible, according to Spanish researchers.

Marathoner’s brain eats itself, effect is reversible: Spanish researchers

HQ Team April 6, 2025: Marathons may affect the brain causing the organ to eat itself to make up for fuel lost during.

by HealthQuill
April 6, 2025
0 Comments

Remember that Covid-19 is still with us, continuously evolving and forming new lineages and we still need to stay ahead of it. Maintaining a cautious vigilance rather than undue panic is the need of the day.

Health Research

COVID-19 increases risk of other infections, study finds

HQ Team April 5, 2025: A recent study reveals that COVID-19 patients face increased risks of other infections for at least a year.

by HealthQuill
April 5, 2025
0 Comments

Indian allopathic doctors will require a unique identification number (UID) to practice in the county, the National Medical Commission, a regulatory body for medical professionals, stated.

Health Medical Opinion

Marriage or work: The unseen battle of female Indian doctors

Becoming a doctor is not just the pinnacle of an average Indian student’s academic dreams but also a platform that bridges the status.

by HealthQuill
April 5, 2025
0 Comments

AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from the European Union.

Drugs Health Pharma

AstraZeneca’s lung cancer drug combination gets EU approval

HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.

by HealthQuill
April 4, 2025
0 Comments

Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European Union, the companies announced.

Drugs Medical Pharma

EU green lights AstraZeneca, Daiichi’s treatment for breast cancer

HQ Team April 4, 2025: Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European.

by HealthQuill
April 4, 2025
0 Comments

Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and Drug Administration, according to a statement.

Drugs Health Medical

Amgen gets US approval to treat immunoglobulin G4-related disease

HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.

by HealthQuill
April 4, 2025
0 Comments

Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development assistance (ODA) — a barometer for international aid flow, according to a concept paper from the Africa Centres for Disease Control and Prevention.

Climate Health Medical

Africa’s health sector facing ‘unprecedented’ financial crisis: CDC

HQ Team April 4, 2025: Africa’s health sector faces an ‘unprecedented’ financing crisis, driven by a sharp fall of 70% in official development.

by HealthQuill
April 4, 2025
0 Comments

The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating dry eyes, over concerns with the data from the trial.

Drugs Health Medical

Aldeyra Therapeutics’ dry eye treatment rejected by USFDA

HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.